-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, U4X2us50FE8UieT1hkvxNYjMkafNOt/0fLYPpuP1y/D2ivdhxj9V4wCnEeqTS+ec EDRVlFyOfHKavCL+ggrDEQ== 0001035704-05-000343.txt : 20050711 0001035704-05-000343.hdr.sgml : 20050711 20050711115132 ACCESSION NUMBER: 0001035704-05-000343 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 4 CONFORMED PERIOD OF REPORT: 20050531 FILED AS OF DATE: 20050711 DATE AS OF CHANGE: 20050711 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PENFORD CORP CENTRAL INDEX KEY: 0000739608 STANDARD INDUSTRIAL CLASSIFICATION: GRAIN MILL PRODUCTS [2040] IRS NUMBER: 911221360 STATE OF INCORPORATION: WA FISCAL YEAR END: 0831 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-11488 FILM NUMBER: 05947289 BUSINESS ADDRESS: STREET 1: 7094 SOUTH REVERE PARKWAY CITY: ENGLEWOOD STATE: C0 ZIP: 80112-3932 BUSINESS PHONE: 303-649-1900 MAIL ADDRESS: STREET 1: 7094 SOUTH REVERE PARKWAY STREET 2: - CITY: ENGLEWOOD STATE: C0 ZIP: 80112-3932 FORMER COMPANY: FORMER CONFORMED NAME: PENWEST LTD DATE OF NAME CHANGE: 19920703 10-Q 1 d26895e10vq.htm FORM 10-Q e10vq
Table of Contents

 
 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

    (Mark One)

     
þ   QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended May 31, 2005

OR

     
o   TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

                    For the transition period from                      to                     

Commission File No. 0-11488

PENFORD CORPORATION

(Exact name of registrant as specified in its charter)
     
Washington   91-1221360
     
(State or Other Jurisdiction of
Incorporation or Organization)
  (I.R.S. Employer
Identification No.)
     
7094 South Revere Parkway,
Centennial, Colorado
 
80112-3932
     
(Address of Principal Executive Offices)   (Zip Code)

Registrant’s telephone number, including area code: (303) 649-1900

Former Address: 7094 South Revere Parkway, Englewood, Colorado 80112-3932

Indicate by a check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Yes þ  No o

Indicate by checkmark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act).
Yes þ  No o

The net number of shares of the Registrant’s common stock (the Registrant’s only outstanding class of stock) outstanding as of July 7, 2005 was 8,825,133.

 
 

 


Table of Contents

PENFORD CORPORATION AND SUBSIDIARIES

INDEX

         
    Page  
       
 
       
       
 
       
    3  
 
       
    4  
 
       
    5  
 
       
    6  
 
       
    13  
 
       
    19  
 
       
    19  
 
       
       
 
       
    20  
 
       
    21  
 Certification of CEO Pursuant to Section 302
 Certification of CFO Pursuant to Section 302
 Certification of CEO & CFO Pursuant to Section 906

2


Table of Contents

PART I — FINANCIAL INFORMATION

Item 1: Financial Statements

PENFORD CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS
                 
    May 31,     August 31,  
(In thousands, except per share data)   2005     2004  
    (Unaudited)          
ASSETS
               
 
               
Current assets:
               
Cash
  $ 2,330     $ 5,915  
Trade accounts receivable, net
    35,841       38,703  
Inventories
    38,872       31,807  
Prepaid expenses
    3,541       4,124  
Other
    2,995       3,031  
 
           
Total current assets
    83,579       83,580  
 
               
Property, plant and equipment, net
    127,896       130,392  
Deferred income taxes
    13,622       13,462  
Restricted cash value of life insurance
    10,037       12,623  
Goodwill, net
    21,836       20,171  
Other intangible assets, net
    2,222       2,299  
Other assets
    3,059       3,269  
 
           
Total assets
  $ 262,251     $ 265,796  
 
           
 
               
LIABILITIES AND SHAREHOLDERS’ EQUITY
               
 
               
Current liabilities:
               
Accounts payable
  $ 37,250     $ 25,169  
Accrued pension liability
    1,589       3,151  
Accrued liabilities
    8,852       10,200  
Current portion of long-term debt
    5,637       4,775  
 
           
Total current liabilities
    53,328       43,295  
 
               
Long-term debt
    62,421       75,551  
Other post-retirement benefits
    13,092       12,598  
Deferred income taxes
    18,997       20,809  
Other liabilities
    17,632       17,824  
 
           
Total liabilities
    165,470       170,077  
 
               
Shareholders’ equity:
               
Preferred stock, par value $1.00 per share, authorized 1,000 shares, none issued
           
Common stock, par value $1.00 per share, authorized 29,000 shares, issued 10,806 and 10,784 shares, respectively
    10,806       10,784  
Additional paid-in capital
    37,236       36,911  
Retained earnings
    71,764       75,585  
Treasury stock, at cost, 1,981 shares
    (32,757 )     (32,757 )
Accumulated other comprehensive income
    9,732       5,196  
 
           
Total shareholders’ equity
    96,781       95,719  
 
           
Total liabilities and shareholders’ equity
  $ 262,251     $ 265,796  
 
           

The accompanying notes are an integral part of these statements.

3


Table of Contents

PENFORD CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)

                                 
    Three months ended     Nine months ended  
    May 31,     May 31,     May 31,     May 31,  
(In thousands, except per share data)   2005     2004     2005     2004  
Sales
  $ 76,101     $ 72,484     $ 217,385     $ 207,136  
Cost of sales
    66,061       60,461       196,956       175,393  
 
                       
Gross margin
    10,040       12,023       20,429       31,743  
 
                               
Operating expenses
    6,783       6,156       18,576       17,330  
Research and development expenses
    1,447       1,595       4,290       4,551  
Restructure costs, net
          384             1,125  
 
                       
 
                               
Income (loss) from operations
    1,810       3,888       (2,437 )     8,737  
 
                               
Non-operating income, net
    1,209       505       1,661       1,010  
Interest expense
    1,457       1,060       4,077       3,352  
 
                       
 
                               
Income (loss) before income taxes
    1,562       3,333       (4,853 )     6,395  
 
                               
Income tax expense (benefit)
    (1,023 )     1,014       (2,620 )     2,196  
 
                       
 
                               
Net income (loss)
  $ 2,585     $ 2,319     $ (2,233 )   $ 4,199  
 
                       
 
                               
Weighted average common shares and equivalents outstanding:
                               
Basic
    8,825       8,771       8,822       8,713  
Diluted
    8,937       8,933       8,822       8,835  
 
                               
Earnings (loss) per share:
                               
Basic
  $ 0.29     $ 0.26     $ (0.25 )   $ 0.48  
Diluted
  $ 0.29     $ 0.26     $ (0.25 )   $ 0.48  
 
                               
Dividends declared per common share
  $ 0.06     $ 0.06     $ 0.18     $ 0.18  

The accompanying notes are an integral part of these statements.

4


Table of Contents

PENFORD CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOW

(Unaudited)

                 
    Nine Months Ended  
    May 31,     May 31,  
(In thousands)   2005     2004  
Cash flows from operating activities:
               
Net income (loss)
  $ (2,233 )   $ 4,199  
Adjustments to reconcile net income (loss) to net cash provided by operations:
               
Depreciation and amortization
    12,992       13,374  
Deferred income taxes
    (2,091 )     (753 )
Loss on early extinguishment of debt
          665  
Gain on sale of investment
    (736 )      
Other
    (95 )     1,136  
Change in assets and liabilities:
               
Trade accounts receivable
    3,988       (4,198 )
Prepaid expenses
    641       512  
Inventories
    (5,639 )     (3,984 )
Accounts payable and accrued liabilities
    9,985       4,002  
Taxes payable
    (1,650 )     88  
Other
    111       879  
 
           
 
               
Net cash provided by operating activities
    15,273       15,920  
 
           
 
               
Cash flows from investing activities:
               
Investment in property, plant and equipment, net
    (6,553 )     (8,007 )
Proceeds from investments
    3,525        
Other
    (84 )     (210 )
 
           
 
               
Net cash used in investing activities
    (3,112 )     (8,217 )
 
           
 
               
Cash flows from financing activities:
               
Proceeds from revolving line of credit
    3,000       35,975  
Payments on revolving line of credit
    (13,591 )     (65,083 )
Proceeds from long-term debt
          50,039  
Payments of long-term debt
    (3,574 )     (24,934 )
Exercise of stock options
    215       1,922  
Payment of loan fees
    (163 )     (1,733 )
Payment of dividends
    (1,588 )     (1,563 )
 
           
 
               
Net cash used in financing activities
    (15,701 )     (5,377 )
 
           
 
               
Effect of exchange rate changes on cash and cash equivalents
    (45 )     (729 )
 
           
 
               
Net increase (decrease) in cash and cash equivalents
    (3,585 )     1,597  
Cash and cash equivalents, beginning of period
    5,915       5,697  
 
           
Cash and cash equivalents, end of period
  $ 2,330     $ 7,294  
 
           

The accompanying notes are an integral part of these statements.

5


Table of Contents

PENFORD CORPORATION AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

     1—BUSINESS

     Penford Corporation (“Penford” or the “Company”) is in the business of developing, manufacturing and marketing specialty natural-based ingredient systems for various applications, including papermaking, textiles and food products. The Company operates manufacturing facilities in the United States, Australia, and New Zealand. Penford’s products provide excellent binding and film-forming characteristics that make customers’ products better through natural, convenient and cost effective solutions. Sales of the Company’s products are generated using a combination of direct sales and distributor agreements.

     The Company has extensive research and development capabilities, which are used in understanding the complex chemistry of carbohydrate-based materials and their application. In addition, the Company has specialty processing capabilities for a variety of modified starches.

     2—BASIS OF PRESENTATION

     Consolidation

     The accompanying condensed consolidated financial statements include the accounts of Penford and its wholly owned subsidiaries. All material intercompany transactions and balances have been eliminated. The condensed consolidated balance sheet at May 31, 2005 and the condensed consolidated statements of operations and cash flows for the interim periods ended May 31, 2005 and 2004 have been prepared by the Company without audit. In the opinion of management, all adjustments, consisting only of normal recurring adjustments, that are necessary to present fairly the financial information have been made. Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles, have been condensed or omitted pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). The results of operations for interim periods are not necessarily indicative of the operating results of a full year or of future operations. The accompanying condensed consolidated financial statements should be read in conjunction with the consolidated financial statements included in the Company’s Annual Report on Form 10-K for the year ended August 31, 2004.

     Recent Accounting Pronouncements

     In November 2004, the Financial Accounting Standards Board (“FASB”) issued Statement No. 151, “Inventory Costs—an Amendment of ARB No. 43, Chapter 4” (“SFAS No. 151”). SFAS No. 151, which is effective for inventory costs incurred during years beginning after June 15, 2005, clarifies the accounting for abnormal amounts of idle facility expense, freight, handling costs, and wasted material, requiring that those items be recognized as current-period charges. In addition, SFAS No. 151 requires that allocation of fixed production overheads be based on the normal capacity of the production facilities. The adoption of SFAS No. 151 beginning September 1, 2005 is not expected to have a material effect on the Company’s results of operation, financial position or liquidity.

     In December 2004, the FASB issued Statement No. 123 (revised 2004), “Share-Based Payment” (“SFAS No. 123R”). SFAS No. 123R, which is effective for the first interim or annual period beginning after June 15, 2005, requires all share-based payments to employees, including grants of stock options, to be recognized in the financial statements based on their fair values. In addition, two transition alternatives are permitted at the time of adoption of this statement, restating prior year financial statements or recognizing adjustments to share-based liabilities as the cumulative effect of a change in accounting principle. In April 2005, the SEC postponed the effective date of SFAS No. 123R until the issuer’s first fiscal year beginning after June 15, 2005. Under the current rules, the Company will be required to adopt SFAS No. 123R effective September 1, 2005. In March 2005, the SEC issued Staff Accounting Bulletin No. 107 (“SAB 107”) regarding the SEC’s interpretation of SFAS No. 123R. The Company is currently evaluating the requirements of SFAS No. 123R and SAB 107. The Company expects that the adoption of

6


Table of Contents

SFAS No. 123R will have a material effect on its results of operations and earnings per share. The Company has not yet determined the method of adoption or the effect of adopting SFAS No. 123R, and it has not determined whether the adoption will result in amounts that are similar to the current proforma disclosures pursuant to SFAS No. 123.

     In March 2005, the FASB issued FASB Interpretation No. 47, “Accounting for Conditional Asset Retirement Obligations” (“FIN No. 47”), which requires an entity to recognize a liability for the fair value of a conditional asset retirement obligation when incurred if the liability’s fair value can be reasonably estimated. FIN No. 47 is effective for fiscal years ending after December 15, 2005. The Company is currently evaluating the effect that the adoption will have on its results of operations and financial position, but does not believe it will have a material impact.

     In May 2005, the FASB issued Statement No. 154, “Accounting Changes and Error Corrections” (“SFAS No. 154”), which is effective for accounting changes and corrections of errors made in fiscal years beginning after December 15, 2005. The Company would be required to adopt SFAS No. 154 in fiscal 2007. SFAS No. 154 provides guidance for and reporting of accounting changes and error corrections. It states that retrospective application, or the latest practicable date, is the required method for reporting a change in accounting principle and the reporting of a correction of an error. The Company is evaluating the effect that the adoption of SFAS No. 154 will have on its results of operations and financial position, but does not believe it will have a material impact.

     Stock-based Compensation

     The Company accounts for its stock-based employee compensation related to stock options under the intrinsic value recognition and measurement principles of APB Opinion No. 25, “Accounting for Stock Issued to Employees” and its various interpretations. Accordingly, no compensation expense has been recognized for the stock-based compensation plans other than for the Directors’ Plan and restricted stock awards.

     The following table illustrates the effect on net income and earnings per share if the Company had elected to recognize compensation expense consistent with the provisions prescribed in FASB Statement No. 123, “Accounting for Stock-Based Compensation” (“SFAS No. 123”), as amended. Under SFAS No. 123, compensation expense is measured at the grant date based on the value of the award and is recognized over the vesting period.

                                 
    Three months ended     Nine months ended  
(In thousands, except per share data)   May 31,     May 31,     May 31,     May 31,  
    2005     2004     2005     2004  
Net income (loss), as reported
  $ 2,585     $ 2,319     $ (2,233 )   $ 4,199  
 
                               
Add: Stock-based employee compensation expense included in reported net income, net of tax
    35       21       60       58  
Less: Stock-based employee compensation expense determined under the fair value method for all awards, net of tax
    (153 )     (263 )     (501 )     (953 )
 
                       
Pro forma net income (loss)
  $ 2,467     $ 2,077     $ (2,674 )   $ 3,304  
 
                               
Earnings (loss) per share:
                               
Reported basic earnings (loss) per common share
  $ 0.29     $ 0.26     $ (0.25 )   $ 0.48  
 
                       
Reported diluted earnings (loss) per common share
  $ 0.29     $ 0.26     $ (0.25 )   $ 0.48  
 
                       
Pro forma basic earnings (loss) per common share
  $ 0.28     $ 0.24     $ (0.30 )   $ 0.38  
 
                       
Pro forma diluted earnings (loss) per common share
  $ 0.28     $ 0.23     $ (0.30 )   $ 0.37  
 
                       

7


Table of Contents

     3—INVENTORIES

     The components of inventory are as follows:

                 
    May 31,     August 31,  
    2005     2004  
    (In thousands)  
Raw materials
  $ 19,443     $ 13,996  
Work in progress
    681       687  
Finished goods
    18,748       17,124  
 
           
Total inventories
  $ 38,872     $ 31,807  
 
           

     4—PROPERTY, PLANT AND EQUIPMENT

                 
    May 31,     August 31,  
    2005     2004  
    (In thousands)  
Land
  $ 16,820     $ 15,952  
Plant and equipment
    298,364       293,721  
Construction in progress
    15,203       10,526  
 
           
 
    330,387       320,199  
Accumulated depreciation
    (202,491 )     (189,807 )
 
           
Net property, plant and equipment
  $ 127,896     $ 130,392  
 
           

     Changes in Australian and New Zealand currency exchange rates have increased net property, plant and equipment in the first nine months of fiscal 2005 by approximately $3.4 million.

     5—DEBT

     At May 31, 2005, the Company had $23.5 million outstanding under its revolving credit facilities and $44.5 million in term loans. Effective November 2004, Penford obtained an amendment to the funded debt ratio covenant, a ratio of earnings before interest, depreciation and taxes, as defined, to total debt, in its credit facility agreement. The Company’s lenders agreed to exclude $8.4 million, a majority of the nonrecurring strike-related costs, from the calculation of the funded debt ratio. The agreement was also amended to increase the funded debt ratio threshold to 3.5 for the first half of fiscal 2005, to 3.25 for the third quarter of fiscal 2005, and to 3.0 thereafter. The maximum capital expenditure level was reduced from $20 million to $15 million for fiscal 2005. Pursuant to the terms of the credit agreement, Penford’s borrowing ability was $12.4 million at May 31, 2005. The Company was in compliance as of May 31, 2005 and expects to be in compliance with these revised covenants for the remainder of fiscal 2005.

     6—TAXES

     The Company’s effective tax rate for the three- and nine-month periods ended May 31, 2005 and 2004 varied from the U.S. federal statutory rate primarily due to U.S. tax credits related to research and development and the favorable tax effect of export sales from the U.S. On a quarterly basis, the Company reviews its estimate of the effective income tax rate expected to be applicable for the full fiscal year. This rate is used to calculate income tax expense or benefit on year-to-date pre-tax income or loss. Income tax expense or benefit for the current interim period is the difference between the computed year-to-date income tax amount and the tax expense or benefit reported for previous quarters. In reviewing its effective tax rate, the Company uses estimates of the amounts of permanent differences between book and tax accounting and projections of fiscal year pre-tax income or loss. Currently, the Company’s best estimate of the annual effective tax rate is 54%. This rate differs from that used in the first half of fiscal 2005 because permanent differences and credits had a greater impact on the tax rate due to changes in projected financial results for the full fiscal year. The tax benefit recognized in the third quarter of fiscal

8


Table of Contents

2005 reflects the Company’s current estimated tax rate applied to year-to-date pre-tax losses, and includes an adjustment increasing its tax benefit related to its first half pre-tax losses by $1.9 million.

     7—OTHER COMPREHENSIVE INCOME

     The components of total comprehensive income (loss) are as follows:

                                 
    Three months ended     Nine months ended  
    May 31,     May 31,     May 31,     May 31,  
    2005     2004     2005     2004  
            (In thousands)          
Net income (loss)
  $ 2,585     $ 2,319     $ (2,233 )   $ 4,199  
Foreign currency translation adjustments
    (1,796 )     (4,122 )     4,657       4,283  
Change in unrealized gains on derivative instruments that qualify as cash flow hedges
    (137 )     82       (121 )     823  
 
                       
Total comprehensive income (loss)
  $ 652     $ (1,721 )   $ 2,303     $ 9,305  
 
                       

     8—NON-OPERATING INCOME, NET

     Non-operating income, net consists of the following:

                                 
    Three months ended     Nine months ended  
    May 31,     May 31,     May 31,     May 31,  
    2005     2004     2005     2004  
            (In thousands)          
Loss on early extinguishment of debt
  $     $     $     $ (665 )
Gain on sale of investment
    736             736       150  
Royalty and licensing income
    436       434       963       1,197  
Other
    37       71       (38 )     328  
 
                       
Total
  $ 1,209     $ 505     $ 1,661     $ 1,010  
 
                       

     In the third quarter of fiscal 2005, the Company sold a majority of its investment in a small Australian start-up company and recognized a $0.7 million pre-tax gain on the transaction.

     In October 2003, Penford refinanced its existing secured credit and inventory financing credit agreements and wrote off the unamortized deferred transaction costs related to these credit agreements. In November 2002, the Company licensed the rights to its resistant starch intellectual property portfolio for applications in human nutrition. The initial licensing fee of $2.25 million received in November 2002 is being amortized over the life of the licensing agreement. In addition, the Company receives royalty income as a percentage of its licensee’s sales of resistant starch for a period of seven years or until a maximum of $11 million in royalties has been received by Penford. The royalty payments are subject to a minimum of $7 million over the first five years of the licensing agreement.

9


Table of Contents

     9 – PENSION AND POST-RETIREMENT BENEFIT PLANS

     The following represents the net periodic pension and post-retirement benefit costs and related components in accordance with SFAS No. 132 (R) for the three and nine months ended May 31, 2005 and 2004.

                                 
Defined benefit pension plans   Three months ended     Nine months ended  
    May 31,     May 31,     May 31,     May 31,  
    2005     2004     2005     2004  
            (In thousands)          
Service cost
  $ 266     $ 229     $ 799     $ 686  
Interest cost
    516       472       1,549       1,417  
Expected return on plan assets
    (467 )     (434 )     (1,401 )     (1,302 )
Amortization of transition obligation
          30             90  
Amortization of prior service cost
    49       27       146       82  
Amortization of actuarial losses
    120       110       360       328  
 
                       
Net periodic benefit cost
  $ 484     $ 434     $ 1,453     $ 1,301  
 
                       
                                 
Post-retirement health care plans   Three months ended     Nine months ended  
    May 31,     May 31,     May 31,     May 31,  
    2005     2004     2005     2004  
            (In thousands)          
Service cost
  $ 88     $ 126     $ 264     $ 379  
Interest cost
    194       213       581       639  
Amortization of prior service cost
    (38 )           (114 )      
Amortization of actuarial losses
    9       15       29       44  
 
                       
Net periodic benefit cost
  $ 253     $ 354     $ 760     $ 1,062  
 
                       

     The net post-retirement benefit costs for the three and nine months ended May 31, 2005 declined compared to the same periods last year due to plan changes retroactive to September 1, 2004 pursuant to a new union contract at the Company’s Iowa manufacturing facility.

10


Table of Contents

     10—SEGMENT REPORTING

     Financial information for the Company’s three segments is presented below. The first two segments, Industrial Ingredients—North America and Food Ingredients—North America, are broad categories of end-market users, primarily served by the Company’s U.S. operations. The third segment is the Company’s geographically separate operations in Australia and New Zealand, which are engaged primarily in the food ingredients business. A fourth item for “corporate and other” activity is presented to provide reconciliation to amounts reported in the condensed consolidated financial statements. Corporate and other represents the activities related to the corporate headquarters such as public company reporting, personnel costs of the executive management team, corporate-wide professional services and elimination and consolidation entries. The elimination of intercompany sales between Australia/New Zealand operations and Food Ingredients—North America of $163,000 and $881,000 for the three and nine month periods ended May 31, 2005, respectively, and $192,000 and $459,000 in the three and nine month periods ended May 31, 2004, respectively, is presented separately since the chief operating decision maker views segment results prior to intercompany eliminations.

                                 
    Three months ended     Nine months ended  
    May 31,     May 31,     May 31,     May 31,  
    2005     2004     2005     2004  
            (In thousands)          
Sales:
                               
Industrial Ingredients—North America
  $ 38,625     $ 38,679     $ 109,394     $ 107,006  
Food Ingredients—North America
    13,911       11,417       38,035       34,283  
Australia/New Zealand operations
    23,728       22,580       70,837       66,306  
Intercompany sales
    (163 )     (192 )     (881 )     (459 )
 
                       
 
  $ 76,101     $ 72,484     $ 217,385     $ 207,136  
 
                       
 
                               
Income (loss) from operations:
                               
Industrial Ingredients—North America (1)
  $ 1,842     $ 2,964     $ (1,944 )   $ 6,079  
Food Ingredients—North America
    1,825       1,096       4,320       3,714  
Australia/New Zealand operations (2)
    (105 )     1,692       143       3,500  
Corporate and other
    (1,752 )     (1,864 )     (4,956 )     (4,556 )
 
                       
 
  $ 1,810     $ 3,888     $ (2,437 )   $ 8,737  
 
                       
 
(1)   Restructuring costs of $487,000 have been included in income from operations in the nine month periods ended May 31, 2004.
 
(2)   Restructuring costs of $384,000 and $638,000 have been included in income from operations in the three and nine months ended May 31, 2004, respectively.
                 
    May 31,     August 31,  
    2005     2004  
    (In thousands)  
Total assets:
               
Industrial Ingredients–North America
  $ 97,377     $ 101,620  
Food Ingredients—North America
    32,399       32,323  
Australia/New Zealand operations
    107,067       99,344  
Corporate and other
    25,408       32,509  
 
           
 
  $ 262,251     $ 265,796  
 
           

11


Table of Contents

     11—EARNINGS (LOSS) PER SHARE

     Basic earnings (loss) per share reflects only the weighted average common shares outstanding during the period. Diluted earnings (loss) per share reflects weighted average common shares outstanding and the effect of any dilutive common stock equivalent shares. The following table presents the computation of diluted weighted average shares outstanding for the three and nine months ended May 31, 2005 and 2004.

                                 
    Three months ended     Nine months ended  
    May 31,     May 31,     May 31,     May 31,  
    2005     2004     2005     2004  
            (In thousands)          
Weighted average common shares outstanding
    8,825       8,771       8,822       8,713  
Net effect of dilutive stock options
    112       162             122  
 
                               
 
                       
Weighted average common shares, outstanding, assuming dilution
    8,937       8,933       8,822       8,835  
 
                       

Diluted earnings per share is calculated by dividing net income by the average common shares outstanding plus additional common shares that would have been outstanding assuming the exercise of in-the-money stock options, using the treasury stock method. Weighted-average stock options to purchase 372,000 and 1,096,065 common stock for the three and nine months ended May 31, 2005 and 210,000 and 254,820 options to purchase common stock for the three and nine months ended May 31, 2004 were excluded from the calculation of diluted earnings per share because they were antidilutive.

     12—LITIGATION

     In October 2004, Penford Products Co. (“Penford Products”), a wholly-owned subsidiary of the Company, was served with a lawsuit filed by Graphic Packaging International, Inc. (“Graphic”) in the Fourth Judicial District, Ouachita Parish, State of Louisiana. The petition seeks monetary damages for alleged breach of contract, negligence and tortious misrepresentation. These claims arise out of an alleged agreement obligating Penford Products to supply goods to Graphic and Penford Products’ alleged breach of such agreement, together with conduct related to such alleged breach. Penford has filed an answer generally denying all liability and has countersued for damages. Discovery is proceeding in this case. The Company cannot at this time determine the likelihood of any outcome or estimate damages, if any.

12


Table of Contents

Item 2: Management’s Discussion and Analysis of Financial Condition and Results of Operations

Forward-looking Statements

     The statements contained in this Quarterly Report on Form 10-Q (“Quarterly Report”) that are not historical facts, including, but not limited to statements found in the Notes to Condensed Consolidated Financial Statements and in Item 2 – Management’s Discussion and Analysis of Financial Condition and Results of Operations, are forward-looking statements that represent management’s beliefs and assumptions based on currently available information. Forward-looking statements can be identified by the use of words such as “believes,” “may,” “will,” “looks,” “should,” “could,” “anticipates,” “expects,” or comparable terminology or by discussions of strategies or trends.

     Although the Company believes that the expectations reflected in such forward-looking statements are reasonable, it cannot give any assurances that these expectations will prove to be correct. Such statements by their nature involve substantial risks and uncertainties that could significantly affect expected results. Actual future results could differ materially from those described in such forward-looking statements, and the Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Among the factors that could cause actual results to differ materially are the risks and uncertainties discussed in this Quarterly Report, including those referenced above, and those described from time to time in other filings with the Securities and Exchange Commission which include, but are not limited to, competition; the possibility of interruption of business activities due to equipment problems, accidents, strikes, weather or other factors; product development risk; changes in corn and other raw material prices and availability; changes in general economic conditions or developments with respect to specific industries or customers affecting demand for the Company’s products including unfavorable shifts in product mix; unanticipated costs, including labor costs, expenses or third party claims; the risk that results may be affected by construction delays, cost overruns, technical difficulties, nonperformance by contractors or changes in capital improvement project requirements or specifications; interest rate and energy cost volatility; foreign currency exchange rate fluctuations; changes in assumptions used for determining employee benefit expense and obligations; changes in the assumptions used to determine the effective income tax rate; or other unforeseen developments in the industries in which Penford operates.

Results of Operations

     Executive Overview

     Penford generates revenues, income and cash flows by developing, manufacturing and marketing specialty natural-based ingredient systems for industrial and food applications. The Company develops and manufactures ingredients with starch as a base which provide value-added applications to its customers. Penford’s starch products are manufactured primarily from corn, potatoes, and wheat, and are used as binders and coatings in paper and food production.

     In analyzing business trends, management considers a variety of performance and financial measures, including sales revenue growth, sales volume growth, gross margins and operating income of the Company’s business segments. Penford manages its business in three segments. The first two, Industrial Ingredients—North America and Food Ingredients—North America, are broad categories of end-market users, served by operations in the United States. The third segment is the Company’s operations in Australia and New Zealand, which operations are engaged primarily in the food ingredients business.

13


Table of Contents

     Consolidated sales for the three months ended May 31, 2005 increased 5% to $76.1 million from $72.5 million in the third quarter of fiscal 2004. Quarterly sales increases were driven by higher volumes in the Food Ingredients—North America and Australian operations, improved pricing in the Industrial Ingredients—North America segment and a stronger Australian dollar. Quarterly gross margin as a percent of sales declined to 13.2% in the third quarter of fiscal 2005 from 16.6% in the same quarter last year due to higher energy, freight and petroleum-based chemical costs in all business segments. Third quarter 2004 operating income included a $0.4 million pre-tax charge related to restructuring costs in the Australian business segment.

     Year-to-date sales rose 5% to $217.4 million from $207.1 million last year, reflecting favorable foreign exchange rates, which contributed 2% of the consolidated sales growth, sales volume improvement in the Australia/New Zealand and Food Ingredients—North America business segments, and improved pricing and mix in the North American operations. Operating loss for the nine months ended May 31, 2005 was $2.4 million compared to income of $8.7 million for the same nine-month period last year. Gross margin as a percent of sales declined to 9.4% from 15.3% last year on $4 million of incremental operating costs related to the Cedar Rapids strike which was settled mid-first quarter, higher energy and chemical costs, and higher manufacturing expenses in Australia. Year-to-date operating income for fiscal 2004 included $1.1 million in pre-tax restructuring costs in the Australian and Industrial Ingredients—North America businesses.

     Fiscal 2005 third quarter and year-to-date operating expenses increased by $0.6 million and $1.2 million, respectively, primarily due to increases in professional fees associated with the initial attestation on internal controls as required by the Sarbanes-Oxley Act of 2002 and higher employee costs. A discussion of segment results of operations and the effective tax rate follows.

     Sales

     Fiscal 2005 third quarter sales of $38.6 million at the Industrial Ingredients—North America business unit were comparable to sales in the third quarter of last year. Sales volumes declined 6% due to reduced shipments of lower value-added formulations. The reduction in sales volumes was offset by improvements in product mix and unit pricing in core, international and specialty product categories. Sales of specialty starches rose 10% in the third quarter of fiscal 2005 over the same period last year. Sales for the nine-month period ended May 31, 2005 increased by 2% over the same period in fiscal 2004 to $109.4 million. The favorable effects of product mix, higher average selling prices and a 35% increase in sales of higher margin specialty starches were offset by a 3% year-to-date sales volume decline.

     Sales of $23.7 million for the third quarter of fiscal 2005 at the Australia/New Zealand operations rose 5% over the same period of fiscal 2004 on strong foreign currency exchange rates and a sales volume increase of 3%. Third quarter sales in local currency were comparable to the same quarter last year. These positive impacts were offset by competitive pricing pressures from imported products as the Australian dollar continued to appreciate. Fiscal 2005 year-to-date sales of $70.8 million grew 7% over the same period last year. Strong Australian and New Zealand foreign currency exchange rates contributed 6% of the revenue increase, with the remainder attributable to volume growth of 7% offset by unfavorable product mix and continued offshore competition. In local currency, sales rose 2%.

     Third quarter fiscal 2005 sales for the Food Ingredients—North America business of $13.9 million expanded $2.5 million, or 22%, compared to the third quarter of last year on volume increases of 21%. Sales of high-margin formulations for the nutrition, or low-carbohydrate, market were strong, accounting for approximately $1.8 million of the sales growth in the third quarter. The Company expects that fourth quarter sales for nutrition food applications will approximate third quarter sales, but that this order level will not be sustained into fiscal 2006. Sales for the nine months ended May 31, 2005 grew $3.8 million, or 11%, to $38.0 million compared to $34.3 million in the same period in fiscal 2004. Volume increases contributed 8% of the sales growth and the remainder is due to favorable product mix. Sales of nutrition applications represented $2.7 million of the nine-month revenue increase.

14


Table of Contents

     Income from operations

     Income from operations for the third quarter of 2005 at Penford’s Industrial Ingredients—North America business unit declined to $1.8 million from $3.0 million for the prior year quarter. Gross margin as a percent of sales was 13.0% in the quarter ended May 31, 2005 compared to 15.0% for the same period last year. The positive impact of improved unit pricing and sales of higher margin specialty starches was offset by continued high chemical and energy costs, which increased by $2.1 million over the prior year quarter, and by increases in other manufacturing expenses. Losses from operations for the first nine months of fiscal 2005 were $1.9 million compared to income of $6.1 million in fiscal 2004. The primary factors contributing to this decrease were incremental costs of approximately $4 million related to the labor strike at the Company’s Iowa manufacturing facility which ended mid-first quarter of fiscal 2005, and increased energy and chemical costs of $4.5 million. Included in year-to-date fiscal 2004 operating income was a $0.5 million pre-tax charge related to a workforce reduction in this business segment.

     Income from operations at the Company’s Australia/New Zealand operations was a loss of $0.1 million for the quarter ended May 31, 2005 compared to income of $1.7 million last year. Third quarter gross margin as a percent of sales decreased from 15.0% last year to 5.1% in the current year quarter. Approximately one-half of the margin decline was attributable to rising costs of oil-based manufacturing inputs, primarily freight, energy and chemicals. The remainder of the decrease is due to lower plant yields and utilization as processes and equipment are being reconfigured to manufacture different product lines. Fiscal 2005 year-to-date operating income decreased by $3.4 million to $0.1 million compared to the prior year period and gross margin as a percent of sales was 5.9% compared to 12.0% last year. The declines in gross margin and operating income for the nine-month period compared to last year are due to the same factors and cost increases as for the third quarter. Included in fiscal 2004 year-to-date operating results was $0.6 million of severance costs related to workforce reductions.

     Third quarter 2005 income from operations at the Food Ingredients—North American business unit grew 67% from $1.1 million last year to $1.8 million. Gross margin as a percent of sales improved to 27.4% from 24.8% last year on a quarterly sales volume increase of 21%, higher margins generated by sales of low carbohydrate product applications, and improved plant utilization. Fiscal 2005 year-to-date operating income increased $0.6 million to $4.3 million compared to the same period last year and gross margin as a percent of sales for both nine-month periods was 25.4%.

     Corporate operating expenses

     Corporate operating expenses for the three months ended May 31, 2005 declined $0.1 million compared to the prior year period as a result of lower overall discretionary spending. Operating expenses for fiscal 2005 year-to-date increased by $0.4 million over the prior year period primarily due to increases in professional fees associated with the initial attestation on internal controls required by the Sarbanes-Oxley Act of 2002.

     Interest and taxes

     Fiscal 2005 interest expense increased by $0.4 million and $0.7 million, respectively, for the three- and nine-month periods ended May 31, 2005 compared to the same periods last year on higher short-term interest rates in the United States.

     The Company’s effective tax rate for the three- and nine-month periods ended May 31, 2005 and 2004 varied from the U.S. federal statutory rate primarily due to U.S. tax credits related to research and development and the favorable tax effect of export sales from the U.S. On a quarterly basis, the Company reviews its estimate of the effective income tax rate expected to be applicable for the full fiscal year. This rate is used to calculate income tax expense or benefit on year-to-date pre-tax income or loss. Income tax expense or benefit for the current interim period is the difference between the computed year-to-date income tax amount and the tax expense or benefit reported for previous quarters. In reviewing its effective tax rate, the Company uses estimates of the amounts of permanent differences between book and tax accounting and projections of fiscal year pre-tax income or loss. Currently, the Company’s best estimate of the annual effective tax rate is 54%. This rate differs from that used in the first half of fiscal 2005 because permanent differences and credits had a greater impact on the tax rate due to changes in projected financial results for the full fiscal year. The tax benefit recognized in the third quarter of fiscal

15


Table of Contents

2005 reflects the Company’s current estimated tax rate applied to year-to-date pre-tax losses, and includes an adjustment increasing its tax benefit related to its first half pre-tax losses by $1.9 million.

     Non-operating income, net

     Non-operating income, net consists of the following:

                                 
    Three months ended     Nine months ended  
    May 31,     May 31,     May 31,     May 31,  
    2005     2004     2005     2004  
            (In thousands)          
Loss on early extinguishment of debt
  $     $     $     $ (665 )
Gain on sale of investment
    736             736       150  
Royalty and licensing income
    436       434       963       1,197  
Other
    37       71       (38 )     328  
 
                       
Total
  $ 1,209     $ 505     $ 1,661     $ 1,010  
 
                       

     In the third quarter of fiscal 2005, the Company sold a majority of its investment in a small Australian start-up company and recognized a $0.7 million pre-tax gain on the transaction.

     In October 2003, Penford refinanced its existing secured credit and inventory financing credit agreements and wrote off the unamortized deferred transaction costs related to these credit agreements. In November 2002, the Company licensed the rights to its resistant starch intellectual property portfolio for applications in human nutrition. The initial licensing fee of $2.25 million received in November 2002 is being amortized over the life of the licensing agreement. In addition, the Company receives royalty income as a percentage of its licensee’s sales of resistant starch for a period of seven years or until a maximum of $11 million in royalties has been received by Penford. The royalty payments are subject to a minimum of $7 million over the first five years of the licensing agreement.

Liquidity and Capital Resources

     Penford had working capital of $30.3 million and $40.3 million at May 31, 2005 and August 31, 2004, respectively. Cash flow from operations was $12.0 million and $7.1 million, respectively, for the quarters ended May 31, 2005 and 2004. The increase in operating cash flow was due to the positive impacts of programs to improve assets returns and working capital balances. At May 31, 2005, the Company had $68.0 million outstanding under its revolving credit facilities and term loans, a reduction of $12.3 million since August 31, 2004.

     At May 31, 2005, the Company had $23.5 million outstanding under its revolving credit facilities and $44.5 million in term loans. Effective November 2004, Penford obtained an amendment to the funded debt ratio covenant, a ratio of earnings before interest, depreciation and taxes, as defined, to total debt, in its credit facility agreement. The Company’s lenders agreed to exclude $8.4 million, a majority of the nonrecurring strike-related costs, from the calculation of the funded debt ratio. The agreement was also amended to increase the funded debt ratio threshold to 3.50 for the first half of fiscal 2005, to 3.25 for the third quarter of fiscal 2005, and to 3.0 thereafter. The maximum capital expenditure level was reduced from $20 million to $15 million for fiscal 2005. Pursuant to the terms of the credit agreement, Penford’s borrowing ability was $12.4 million at May 31, 2005. The Company was in compliance as of May 31, 2005 and expects to be in compliance with these revised covenants for the remainder of fiscal 2005.

     The Company paid dividends of $1.6 million during the nine months ended May 31, 2005, which represents a quarterly rate of $0.06 per share, the same per share dividend rate as the nine months ended May 31, 2004. On June 28, 2005, the Board of Directors declared a dividend of $0.06 per common share payable on September 2, 2005 to shareholders of record as of August 12, 2005. Any future dividends will be paid at the discretion of the Company’s board of directors and will depend upon, among other things, earnings, financial condition, cash requirements and availability, and contractual requirements.

16


Table of Contents

Recent Accounting Pronouncements

     In November 2004, the FASB issued Statement No. 151, “Inventory Costs—an Amendment of ARB No. 43, Chapter 4” (“SFAS No. 151”). SFAS No. 151, which is effective for inventory costs incurred during years beginning after June 15, 2005, clarifies the accounting for abnormal amounts of idle facility expense, freight, handling costs, and wasted material, requiring that those items be recognized as current-period charges. In addition, SFAS No. 151 requires that allocation of fixed production overheads be based on the normal capacity of the production facilities. The adoption of SFAS No. 151 beginning September 1, 2005 is not expected to have a material effect on the Company’s results of operation, financial position or liquidity.

     In December 2004, the FASB issued Statement No. 123 (revised 2004), “Share-Based Payment” (“SFAS No. 123R”). SFAS No. 123R, which is effective for the first interim or annual period beginning after June 15, 2005, requires all share-based payments to employees, including grants of stock options, to be recognized in the financial statements based on their fair values. In addition, two transition alternatives are permitted at the time of adoption of this statement, restating prior year financial statements or recognizing adjustments to share-based liabilities as the cumulative effect of a change in accounting principle. In April 2005, the SEC postponed the effective date of SFAS No. 123R until the issuer’s first fiscal year beginning after June 15, 2005. Under the current rules, the Company will be required to adopt SFAS No. 123R effective September 1, 2005. In March 2005, the SEC issued Staff Accounting Bulletin No. 107 (“SAB 107”) regarding the SEC’s interpretation of SFAS No. 123R. The Company is currently evaluating the requirements of SFAS No. 123R and SAB 107. The Company expects that the adoption of SFAS No. 123R will have a material effect on its results of operations and earnings per share. The Company has not yet determined the method of adoption or the effect of adopting SFAS No. 123R, and it has not determined whether the adoption will result in amounts that are similar to the current proforma disclosures pursuant to SFAS No. 123.

     In March 2005, the FASB issued FASB Interpretation No. 47, “Accounting for Conditional Asset Retirement Obligations” (“FIN No. 47”), which requires an entity to recognize a liability for the fair value of a conditional asset retirement obligation when incurred if the liability’s fair value can be reasonably estimated. FIN No. 47 is effective for fiscal years ending after December 15, 2005. The Company is currently evaluating the effect that the adoption will have on its results of operations and financial position, but does not believe it will have a material impact.

     In May 2005, the FASB issued Statement No. 154, “Accounting Changes and Error Corrections” (“SFAS No. 154”), which is effective for accounting changes and corrections of errors made in fiscal years beginning after December 15, 2005. The Company would be required to adopt SFAS No. 154 in fiscal 2007. SFAS No. 154 provides guidance for and reporting of accounting changes and error corrections. It states that retrospective application, or the latest practicable date, is the required method for reporting a change in accounting principle and the reporting of a correction of an error. The Company is evaluating the effect that the adoption of SFAS No. 154 will have on its results of operations and financial position, but does not believe it will have a material impact.

17


Table of Contents

Risks and Uncertainties

The availability and cost of the agricultural products Penford purchases are vulnerable to weather and other factors beyond its control.

     Approximately 30% of Penford’s manufacturing costs are the costs of agricultural raw materials: corn, wheat flour, and potato starch. Weather conditions, plantings and global supply, among other things, have historically caused volatility in the supply and prices of these agricultural products. The Company may not be able to pass through any increases in the cost of agricultural raw materials to its customers. To manage the price volatility in the commodity markets, the Company may purchase inventory in advance or enter into exchange traded futures or options contracts. Despite these hedging activities, Penford may not be successful in limiting its exposure to market fluctuations in the cost of agricultural raw materials. Increases in the cost of corn, wheat flour, and potato starch due to weather conditions or other factors beyond Penford’s control and that cannot be passed through to customers will reduce Penford’s future profitability.

Increases in energy costs will reduce the Company’s profitability.

     Electricity and natural gas comprise approximately 15% of the cost of manufacturing the Company’s products in North America. Natural gas is used extensively in the Industrial Ingredients – North America business to dry the starch products. The prices of these inputs to the manufacturing process fluctuate based on anticipated changes in supply and demand, weather and the prices of alternative fuels. Penford may use short-term purchase contracts or exchange traded futures or option contracts to reduce the price volatility of natural gas. Penford may not be able to pass on increases in energy costs to its customers and margins and profitability would be adversely affected.

The loss of a major customer could have an adverse effect on Penford’s results of operations.

     None of the Company’s customers constituted 10% of sales in the last three fiscal years. However, in the nine months of fiscal 2005, sales to the top ten customers and sales to the largest customer represented 44% and 9.0%, respectively, of total consolidated net sales. Customers place orders on an as-needed basis and generally can change their suppliers without penalty. If the Company lost one or more of its major customers, or if one or more of its customers significantly reduced its orders, sales and results of operations would be adversely affected.

In order to be successful, Penford must retain and motivate key employees.

     In order to be successful, the Company must retain and motivate executives and other key employees. In particular, hiring and retaining qualified personnel in management, research and development, sales and marketing, manufacturing and finance is critical to Penford’s future. Penford faces intense competition for its personnel needs. The loss of key employees could have a significant impact on the Company’s results of operations and stock price.

Changes in interest rates will affect Penford’s profitability.

     At May 31, 2005, approximately $58.3 million of the Company’s outstanding debt is subject to variable interest rates which move in direct proportion to the London InterBank Offered Rate (“LIBOR”) or the Australian Bank Bill Buying Rate (BBSY). Significant changes in these interest rates would materially affect Penford’s profitability.

Unanticipated changes in tax rates or exposure to additional income tax liabilities could affect Penford’s profitability.

     Penford is subject to income taxes in the United States, Australia and New Zealand. The effective tax rates could be adversely affected by changes in the mix of earnings in countries with differing statutory tax rates, changes in the valuation of deferred tax assets and liabilities or changes in tax laws. The carrying value of deferred tax assets, which are predominantly in the United States, is dependent on Penford’s ability to generate future taxable income in the United States. The amount of income taxes Penford pays is subject to audit and a material assessment by a governing tax authority could affect profitability.

18


Table of Contents

Profitability is subject to risks associated with changes in foreign exchange currency rates.

     In the ordinary course of business, Penford is subject to risks associated with changing foreign exchange rates. For the nine months ended May 31, 2005, approximately 33% of the Company’s revenue is denominated in currencies other than the U.S. dollar. Penford’s revenues and results of operations are affected by fluctuations in exchange rates between the U.S. dollar and the Australian and New Zealand dollars.

Provisions of Washington law could discourage or prevent a potential takeover.

     Penford is incorporated in the State of Washington and subject to the anti-takeover provisions of the Washington Business Corporation Act (the “Act”), which prohibits the Company from engaging in a ‘business combination” with an “interested shareholder” for a period of three years after the date of the transaction in which the person became an interested shareholder, unless the business combination is approved in a prescribed manner. The application of the anti-takeover provisions of the Act could have the effect of delaying or preventing a change of control in the ownership of the Company.

     Item 3: Quantitative and Qualitative Disclosures About Market Risk.

     The Company is exposed to market risks from adverse changes in interest rates, foreign currency exchange rates and commodity prices. Since August 31, 2004, there have been no significant changes in the Company’s exposure to market risks.

     Item 4: Controls and Procedures.

     Under the supervision and with the participation of management, including the Chief Executive Officer and Chief Financial Officer, the Company has evaluated the effectiveness of the design and operation of its disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended, as of the end of the period covered by this report. Based on that evaluation, the Chief Executive Officer and Chief Financial Officer have concluded that these disclosure controls and procedures are effective such that information related to the Company required to be disclosed in the SEC reports (i) is recorded, processed, summarized and reported within the time periods specified in SEC rules and forms, and (ii) is accumulated and communicated to the Company’s management, including the Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure.

19


Table of Contents

PART II — OTHER INFORMATION

Item 6: Exhibits.

Exhibits

31.1   Certifications of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
 
31.2   Certifications of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
 
32   Certifications of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

20


Table of Contents

SIGNATURES

     Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

         
 
      Penford Corporation
 
       
 
      (Registrant)
 
       
July 11, 2005
      /s/ Steven O. Cordier
 
       
 
      Steven O. Cordier
 
      Senior Vice President and Chief Financial Officer

21


Table of Contents

EXHIBIT INDEX

     
Exhibit No.   Description
 
   
31.1
  Certifications of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
 
   
31.2
  Certifications of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
 
   
32
  Certifications of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

22

EX-31.1 2 d26895exv31w1.htm CERTIFICATION OF CEO PURSUANT TO SECTION 302 exv31w1
 

Exhibit 31.1

CERTIFICATIONS

I, Thomas D. Malkoski, certify that:

     1. I have reviewed this Quarterly Report on Form 10-Q of Penford Corporation;

     2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

     3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

     4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

     a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

     b) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

     c) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

     5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent functions):

     a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

     b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

         
Date: July 11, 2005
  /s/ Thomas D. Malkoski    
 
       
 
  Thomas D. Malkoski    
 
  Chief Executive Officer    

 

EX-31.2 3 d26895exv31w2.htm CERTIFICATION OF CFO PURSUANT TO SECTION 302 exv31w2
 

Exhibit 31.2

CERTIFICATIONS

I, Steven O. Cordier, certify that:

     1. I have reviewed this Quarterly Report on Form 10-Q of Penford Corporation;

     2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

     3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

     4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

     a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

     b) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

     c) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

     5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent functions):

     a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

     b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

     
Date: July 11, 2005
  /s/ Steven O. Cordier
 
   
 
  Steven O. Cordier
 
  Senior Vice President and Chief Financial Officer

 

EX-32.1 4 d26895exv32w1.htm CERTIFICATION OF CEO & CFO PURSUANT TO SECTION 906 exv32w1
 

Exhibit 32

CERTIFICATION PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
(18 U.S.C. SECTION 1350)

          In connection with the Quarterly Report of Penford Corporation (the “Company”) on Form 10-Q for the quarter ended May 31, 2005 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), Thomas D. Malkoski, Chief Executive Officer of the Company, and Steven O. Cordier, Chief Financial Officer of the Company, respectively, do each hereby certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. Section 1350), that to his knowledge:

          (1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

          (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
         
     
  /s/ Thomas D. Malkoski    
  Thomas D. Malkoski   
  Chief Executive Officer   
 

Dated: July 11, 2005
         
     
  /s/ Steven O. Cordier    
  Steven O. Cordier   
  Senior Vice President and Chief Financial Officer   
 

Dated: July 11, 2005

          A signed original of this written statement required by Section 906 has been provided to Penford Corporation and will be retained by Penford Corporation and furnished to the Securities and Exchange Commission or its staff upon request.

 

-----END PRIVACY-ENHANCED MESSAGE-----